Easton Silent on Progress of Cannabis Business
A year ago, in August 2017, Toronto-based specialty pharmaceutical company Easton Pharmaceuticals (OTC: EAPH), paid Canadian-based Alliance Group $1.3 million for an interest in 45 agriculturally zoned acres north of Toronto for the cultivation of cannabis.
Being such a large parcel for the cannabis industry—comprising almost 2 million sf—this was exciting news. If they develop this into cultivation, it could catapult Easton to being a large producer.
But a year later, little is being reported about the progress.
At the time, Alliance Partners was confident all hurdles to grow legalized medical/recreational marijuana would be cleared shortly, leading to production within 6 months from its first greenhouse facility. They expect it to generate several millions of dollars in its first year with good profit margins.
As of June 2018, it reported simply that Alliance was working on the property. No progress has since been reported. Until revenues are generated, Easton will receive 50% of all revenues from Alliance’s other businesses.
Easton’s investment and guarantee on revenues are securitized by Alliance’s larger 135-acre property, appraised at over $8,000,000. Easton retains the option to buy 50% of Alliance’s businesses, which include recycling, manufacturing of industrial products, and waste management with million dollar contracts in place.
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in pharmaceutical sectors and other industries. It currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. These are in various stages of development.
Source Easton press release
{{cta(‘b491434f-c6aa-4547-b3d4-6a7293c8ad67’)}}
Easton Silent on Progress of Cannabis Business
About Cannin: Your Cannabis Stocks Resource
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Hemp stocks
